Evidence map›Paper›PMID 41721212›Full record

ArticleInternational journal of stroke : official journal of the International Stroke Society2026

Atrial fibrillation detection after embolic stroke of undetermined source: Development and validation of the CATCH-AF score.

Lucio D'Anna, Francesco Favruzzo, Claudio Baracchini, Alessandra Pes, Fionn Mag Uidhir, Diletta Rosin, Mariarosaria Valente, Gian Luigi Gigli, Liqun Zhang, Nathan Leung and 29 more

Abstract readValidation Study
In one paragraph

Article in International journal of stroke : official journal of the International Stroke Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

39 authors.

Lucio D'AnnaDepartment of Stroke and Neuroscience, Charing Cross Hospital, Imperial College London NHS Healthcare Trust, London, UK.ORCID 0000-0002-4349-3322
Francesco FavruzzoStroke Unit and Neurosonology Laboratory, Padua University School of Medicine, Padua, Italy.ORCID 0000-0001-8548-6027
Claudio BaracchiniStroke Unit and Neurosonology Laboratory, Padua University School of Medicine, Padua, Italy.
Alessandra PesStroke Unit and Neurosonology Laboratory, Padua University School of Medicine, Padua, Italy.
Fionn Mag UidhirDepartment of Stroke and Neuroscience, Charing Cross Hospital, Imperial College London NHS Healthcare Trust, London, UK.
Diletta RosinClinical Neurology, Udine University Hospital and Department of Medicine (DAME), University of Udine, Udine, Italy.
Mariarosaria ValenteSOSD Stroke Unit, Department Head, Neck, and Neurosciences, Udine University Hospital, Udine, Italy.
Gian Luigi GigliSOSD Stroke Unit, Department Head, Neck, and Neurosciences, Udine University Hospital, Udine, Italy.
Liqun ZhangDepartment of Neuroscience, St George's University Hospital NHS Foundation Trust, London, UK.
Nathan LeungDepartment of Neuroscience, St George's University Hospital NHS Foundation Trust, London, UK.
Manav SohalDepartment of Cardiology, St George's University Hospital NHS Foundation Trust, London, UK.
Simona SaccoDepartment of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy.
Raffaele OrnelloDepartment of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy.ORCID 0000-0001-9501-4031
Federico De SantisDepartment of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy.ORCID 0000-0002-8059-6427
Ubaldo CoppolaDepartment of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy.
Gabriele PrandinDepartment of Brain Sciences, Imperial College London, London, UK.ORCID 0000-0002-5698-4737
Michele RomoliDepartment of Neuroscience, Neurology and Stroke Unit, Bufalini Hospital, Cesena, Italy.
Valentina TudiscoDepartment of Neuroscience, Neurology and Stroke Unit, Bufalini Hospital, Cesena, Italy.
Federica Nicoletta SepeDepartment of Neuroscience, Neurology and Stroke Unit, Bufalini Hospital, Cesena, Italy.
Jianqun GuanDepartment of Cardiology, Hammersmith Hospital, Imperial College London NHS Healthcare Trust, London, UK.
Asha BarnardDepartment of Cardiology, Hammersmith Hospital, Imperial College London NHS Healthcare Trust, London, UK.
Lydia JeffreyDepartment of Cardiology, Hammersmith Hospital, Imperial College London NHS Healthcare Trust, London, UK.
Jake DaganDepartment of Cardiology, Hammersmith Hospital, Imperial College London NHS Healthcare Trust, London, UK.
Tsering DolkarDepartment of Stroke and Neuroscience, Charing Cross Hospital, Imperial College London NHS Healthcare Trust, London, UK.
Irtiza SyedDepartment of Stroke and Neuroscience, Charing Cross Hospital, Imperial College London NHS Healthcare Trust, London, UK.
Soma BanerjeeDepartment of Stroke and Neuroscience, Charing Cross Hospital, Imperial College London NHS Healthcare Trust, London, UK.
Selina EdwardsComprehensive Stroke Service, University College London Hospital, London, UK.
Ceylan SafakComprehensive Stroke Service, University College London Hospital, London, UK.
Roberto AvilaComprehensive Stroke Service, University College London Hospital, London, UK.
Joan CruzComprehensive Stroke Service, University College London Hospital, London, UK.
Ashley LaurieComprehensive Stroke Service, University College London Hospital, London, UK.
Gaurav DesaiComprehensive Stroke Service, University College London Hospital, London, UK.
Maryam HaneefComprehensive Stroke Service, University College London Hospital, London, UK.
Anne IdianComprehensive Stroke Service, University College London Hospital, London, UK.
Arvind ChandrathevaComprehensive Stroke Service, University College London Hospital, London, UK.ORCID 0000-0003-4967-3508
Phang Boon LimDepartment of Cardiology, Hammersmith Hospital, Imperial College London NHS Healthcare Trust, London, UK.
Giovanni MerlinoClinical Neurology, Udine University Hospital and Department of Medicine (DAME), University of Udine, Udine, Italy.
Matteo FoschiDepartment of Neuroscience, Neurology and Stroke Unit, Bufalini Hospital, Cesena, Italy.ORCID 0000-0002-0321-7155
Robert SimisterComprehensive Stroke Service, University College London Hospital, London, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundEmbolic stroke of undetermined source (ESUS) accounts for up to one quarter of ischemic strokes, with occult atrial fibrillation (AF) as a key underlying cause. Implantable cardiac monitors (ICMs) markedly improve AF detection but are limited by cost and resource demands. Existing AF-prediction models show modest accuracy and lack longitudinal validation. We developed and validated the CATCH-AF score to provide a simple, clinically applicable tool for stratifying early and long-term AF risk after ESUS.

methodsWe analyzed 543 consecutive ESUS patients systematically monitored with ICMs. Variable selection used LASSO-penalized Cox regression. Model performance was assessed with time-dependent ROC curves, restricted mean survival time (RMST) analysis, and 10-fold cross-validation. To evaluate geographic generalizability, internal-external cross-validation was performed across seven participating centers, estimating discrimination and calibration for each held-out cohort. Based on the final multivariable model, a point-based score was derived including age, coronary artery disease, heart failure, and prior transient ischemic attack or ischemic stroke.

resultsDuring 1558.5 patient-years of follow-up, 118 patients (22%) developed new AF. The CATCH-AF score showed excellent discrimination (AUC 0.85, 95% CI 0.82-0.89), stable over 4.5 years (0.84-0.87). Compared with low-risk patients (0-2 points), those at high risk (⩾5 points) had a 19-fold higher hazard of AF detection (HR 19.2, 95% CI 9.4-39.4;

conclusionsThe CATCH-AF score provides a robust, interpretable, and easily applicable tool for predicting AF after ESUS, supporting targeted and cost-effective rhythm monitoring.

Indexed as

Atrial FibrillationEmbolic StrokeAgedAged, 80 and overFemaleHumansMaleMiddle AgedRisk FactorsROC Curveatrial fibrillationEmbolic stroke of undetermined sourceimplantable cardiac monitorprediction modelrisk stratification

Identifiers

PMID41721212
PMCPMC13392170

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.